Better Science with Sex and gender in mind Shifting the paradigm in HIV research XIX IAC Washington DC 23 July :30 – 20:30 Dr. Shirin Heidari, IAS-ILF Dr. Rowena Johnston, amfAR
amfAR International Liaison Forum
IAS – Industry Liaison Forum (IAS–ILF) Multi-stakeholder forum of the IAS with the mission to accelerate scientifically promising, ethical HIV research in resource-limited countries, with a particular focus on the role and responsibilities of industry as sponsors and supporters of research. IAS-ILF Strategic Plan To accelerate HIV prevention and treatment research for women and children in resource-limited settings F / T
Gender Editorial policy in 2010 Journal of the International AIDS Society
SEX Biological differences (mostly Binary)
Gender Socially constructed notion of femininity and masculinity (continuum)
Gender role
% of female and male participants in Cure clinical trials
Reporting of gender differences in articles from CT with ARVs
Research – Evidence - Knowledge Knowledge Education Ideas Research design Research results Publication Peer- reviewed Journals Research & Clinical governance Research Funding Body “research must systematically incorporate attention to sex and gender in design, analysis, and interpretation of findings” WHO 2009
Agenda 18:45-18:55 What are the differences between women and men in the context of HIV? From transmission to treatment. By Dr. Linda-Gail Bekker, University of Cape Town 18:55-19:05 Why gender analysis matters in science. By Prof. Londa Schiebinger, Stanford University 19:05-19:15 A practical guide to study design with sex and gender in mind By Prof. Joy Johnson, Canadian Institutes of Health Research (CIHR) 19:15-19:45 Moderated Q and A by co-chairs 19:45-20:20 Shaping the future of HIV science with gender in mind: Moderated discussion Moderated by Ms. Heidi Nass, IAS-ILF
Panel Discussion 19:45-20:20 Shaping the future of HIV science with gender in mind: Moderated discussion Moderator by Ms. Heidi Nass, IAS-ILF Panellists: Dr. Bryan Baugh, Janssen Dr. Gina Brown, Office of AIDS Research, NIH Dr. Pat Fast, IAVI (TBC) Dr. Rowena Johnston, amfAR Ms. Rahab Mwaniki, IAS-ILF Dr. Emma Veitch, PLOS medicine 20:20-20:30Closing Remarks